Compare LOCO & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LOCO | CGC |
|---|---|---|
| Founded | 1980 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Restaurants | Pharmaceuticals and Biotechnology |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 461.7M | 401.0M |
| IPO Year | 2014 | 2023 |
| Metric | LOCO | CGC |
|---|---|---|
| Price | $15.45 | $1.01 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 1 |
| Target Price | ★ $14.17 | N/A |
| AVG Volume (30 Days) | 220.2K | ★ 2.6M |
| Earning Date | 05-07-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 4.65 | ★ 84.17 |
| EPS | ★ 0.70 | N/A |
| Revenue | ★ $401,701,000.00 | $12,759,000.00 |
| Revenue This Year | $3.60 | $8.27 |
| Revenue Next Year | $3.98 | $15.68 |
| P/E Ratio | $21.71 | ★ N/A |
| Revenue Growth | ★ 5.68 | N/A |
| 52 Week Low | $8.99 | $0.84 |
| 52 Week High | $17.40 | $2.38 |
| Indicator | LOCO | CGC |
|---|---|---|
| Relative Strength Index (RSI) | 42.87 | 61.14 |
| Support Level | $13.10 | $1.01 |
| Resistance Level | $15.75 | $1.08 |
| Average True Range (ATR) | 0.60 | 0.04 |
| MACD | -0.17 | 0.01 |
| Stochastic Oscillator | 25.73 | 83.94 |
El Pollo Loco Holdings Inc operates and franchises hundreds of fast-casual chicken restaurants in the United States. It specializes in fire-grilling citrus-marinated chicken and operates in the limited service restaurant market segment. Its offerings include Mexican-inspired menu items, including burritos, tostadas, bowls, salads, and bone-in chicken meals in various portion sizes. It also offers citrus-marinated fire-grilled chicken, along with a range of salsas and dressings that allow customers to customize their meals. The company operates in one operating segment. The majority of the company's revenue is derived from company-operated restaurant revenue.
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.